Ascitic Fluid Cytokines in Chronic Liver Disease: A Possible Prognostic Tool. 2021

Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
Department of Immunology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt.

BACKGROUND Malignant ascites results from imbalance between protein in the peritoneal cavity and absorption of fluids via the lymphatic system. More than 20 interleukins (ILs) are known to play an important role in the protection against tumors. METHODS Ascitic fluid IL-1B, IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ levels were assessed in 45 patients with liver cirrhosis and ascites as judged by histopathological and ultrasonographic findings. They were divided into 2 groups according to presence of hepatic focal lesions. Ten patients with focal hepatic lesions were randomly selected and subjected to analysis of serum levels of IL-2 and IL-10. RESULTS Ascitic fluid IL-4, IL-6 and IL-10 levels were found to be significantly higher in patients with hepatocellular carcinoma (HCC) than patients with cirrhosis. TNF-α, and IFN-γ were also found to be higher in HCC than patients with cirrhosis but with no significance. On the other hand, there was no significant difference in levels of IL-1B and IL-2 between the 2 groups. Ascitic fluid IL-2 and IL-10 levels were found to be higher in ascitic fluid than in serum of the same patients. CONCLUSIONS Ascitic fluid levels of IL-4, IL-6 and IL-10 are higher in HCC patients than patients with cirrhosis alone. Levels of ascitic fluid IL-2 and IL-10 proved to be a better prognostic tool than their levels in sera of the same patients. To conclude, patients with cirrhosis may be subjected to scheduled examination of ascitic fluid cytokines to predict transformation into HCC.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
May 1983, The American journal of gastroenterology,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
August 1977, Annals of internal medicine,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
May 2001, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
January 1994, The Journal of antimicrobial chemotherapy,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
January 1953, Tip Fakultesi mecmuasi,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
August 1993, The American journal of gastroenterology,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
January 2007, Cytokine & growth factor reviews,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
November 1981, The American journal of gastroenterology,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
September 2019, Scientific reports,
Shimaa Atta, and Manal Kamel, and Wafaa Mansour, and Taghreed Hussein, and Kesmat Maher, and Mohamed A Elrefaiy
May 1990, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!